Skip to main content
FDA approves glofitamab for DLBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves glofitamab for DLBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Biologic Therapy
0
0.87
Lymphoma
0
0.7
B-Cell Lymphoma
0
0.99
Follicular Lymphoma
0
0.61
CAR-T
0
0.5
Refractory
0
0.35
Cancer
0
0.26
Remission
0
0.26
Healthcare and Medical Technology
0
0.1
Pain Management
0
0.1
Antigens
0
0.09
Clinical Research
0
0.09
Cytokines
0
0.09
Fatigue
0
0.09
Grant
0
0.09
Immunotherapy
0
0.09
Pain
0
0.09
Receptors
0
0.09
Washington
0
0.09
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Edit Tags